Atrasentan (EXV811)

Atrasentan · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Atrasentan (EXV811), covering 2026-01-22 to 2026-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Managed Access Programs for EXV811, Atrasentan